Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. ATAI Life Sciences N.V. shares valued at $23,120 were purchased by Brand Florian on Nov 16 ’23. At $1.16 per share, Brand Florian acquired 20,000 shares. The insider’s holdings grew to 130,000 shares worth approximately $0.22 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Brand Florian purchased 40,000 shares, netting a total of over 57,968 in proceeds. Following the buying of shares at $1.45 each, the insider now holds 110,000 shares.
Before that, Apeiron Investment Group Ltd. had added 1,214,297 shares to its account. In a trade valued at $1,600,443, the 10% Owner bought ATAI Life Sciences N.V. shares for $1.32 each. Upon closing the transaction, the insider’s holdings increased to 1,214,297 shares, worth approximately $53.58 million.
As published in their initiating research note from Loop Capital on November 01, 2022, ATAI Life Sciences N.V. [ATAI] has been a Buy and the price target has been revised to $18. Analysts at Maxim Group started covering the stock with ‘”a Buy”‘ outlook in a report released in late November. As of November 11, 2021, ROTH Capital has initiated its “Buy” rating for ATAI. Earlier on October 18, 2021, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for ATAI stock.
Analyzing ATAI Stock Performance
During the last five days, there has been a drop of approximately -0.60%. Over the course of the year, ATAI Life Sciences N.V. shares have jumped approximately 18.44%. Shares of the company reached a 52-week high of $2.3150 on 03/08/24 and a 52-week low of $1.3950 on 01/02/24. A 50-day SMA is recorded $1.8541, while a 200-day SMA reached $1.6025. Nevertheless, trading volume fell to 1.09 million shares from 0.88 million shares the previous day.
Support And Resistance Levels for ATAI Life Sciences N.V. (ATAI)
According to the 24-hour chart, there is a support level at 1.6200, which, if violated, would cause prices to drop to 1.5700. In the upper region, resistance lies at 1.7200. The next price resistance is at 1.7700. RSI (Relative Strength Index) is 41.46 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.1993, which suggests the price will decrease in the coming days. Percent R is at 87.76%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Is ATAI Life Sciences N.V. subject to short interest?
Stocks of ATAI Life Sciences N.V. saw a sharp steep in short interest on Feb 29, 2024 dropping by -1.22 million shares to 3.53 million. Data from Yahoo Finance shows that the short interest on Jan 31, 2024 was 4.75 million shares. A decline of -34.56% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.25 of the overall float, the days-to-cover ratio (short ratio) decline to 3.25.
